Private Equity Interest in Women’s Health
Private equity firms Ardian, CVC, and Verdane are eyeing investments in various subsegments of the women’s health market, according to PE Hub. This interest highlights ongoing activity in healthcare sectors by these firms. Exellere Partners and GHO Capital Partners have reached a $950 million agreement to sell a pathology services company to Agilent Therapeutics, as reported in the same source.
Details of the Pathology Services Exit
The sale involves Exellere Partners and GHO Capital Partners exiting their investment in a pathology services company, with the deal valued at $950 million and directed to Agilent Therapeutics. According to PE Hub, this transaction reflects momentum in pathology services. Such exits demonstrate how private equity firms are capitalizing on sector growth.
New Appointments in the Sector
Vistria has announced new appointments, adding to recent developments in private equity and healthcare. These changes come alongside broader investment trends, as noted by PE Hub. The announcements underscore personnel shifts within the industry.
Implications for Emerging Managers
For emerging fund managers, these activities in women’s health and pathology services illustrate current deal opportunities, according to PE Hub.
